Ergotamine Tartrate
1 NDC across 1 manufacturer|0 Generic,1 Brand
Ergotamine Tartrate is used to treat cluster headache, migraine disorders and postpartum hemorrhage, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jul 29, 1982. In 2024, Medicare Part D spent $207K on Ergotamine Tartrate across 138 claims for 61 beneficiaries.
Ergotamine Tartrate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $43.46 to $43.46 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$43.46 – $43.46
per EA
7d Activity
avg +0.7% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Pangea Pharmaceuticals LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Ergotamine Derivative class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing ERGOTAMINE TARTRATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ERGOMAR 2 MG TABLET SUBLINGUAL | $43.4611 per EA | +0.70% |
Frequently Asked Questions
What is Ergotamine Tartrate used to treat?
Ergotamine Tartrate is used to treat cluster headache, migraine disorders and postpartum hemorrhage, per the National Library of Medicine's MED-RT classification.
When did Ergotamine Tartrate become available as a generic?
FDA approved the first generic Ergotamine Tartrate (ANDA) on Jul 29, 1982.
How much does Medicare spend on Ergotamine Tartrate?
In 2024, Medicare Part D spent $207K on Ergotamine Tartrate across 138 claims for 61 beneficiaries.
How many Ergotamine Tartrate products are on the market?
The Ergotamine Tartrate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Ergotamine Tartrate?
NADAC reference prices for Ergotamine Tartrate range from $43.4611 to $43.4611 per EA.
Which manufacturers make Ergotamine Tartrate?
1 manufacturer lists Ergotamine Tartrate in NADAC. Ranked by number of NDCs, the largest are Pangea Pharmaceuticals LLC (1).
How has the price of Ergotamine Tartrate changed recently?
Over the past 7 days, 1 Ergotamine Tartrate NDC rose and 0 fell, with a market-wide average change of +0.7%.